Enzene opens its Continuous Biologics Manufacturing facility in Pune
Enzene says the company is amongst the first movers in end-to-end connected bio manufacturing to have set up a fully automated continuous cGMP compliant manufacturing plant for mAb production.
US FDA approves Sanofi’s Fluzone Quadrivalent Influenza Vaccine
Fluzone High-Dose (Influenza Vaccine) was approved by the FDA in 2009 as a trivalent influenza vaccine, including two influenza A strains and one influenza B strain.
